American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2025
Implementation of an innovative PGY2 pharmacy residency led by a virtual precepting team with a focus on telehealth.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garcia Julie, Null Aaron, Palladino Catherine, Spoutz Laura, Litke Jessica, Bankova Ianitza, White Shelby, Burkett Michael, Ragan Addison, Golterman Lori, Mambourg Scott, Hunt Lindsey
Аннотация
PURPOSE: Remote work and telehealth expanded with the COVID-19 pandemic. Allowances prompted programs to explore innovative ways to expand residency training opportunities. This article describes the development and implementation of the first telehealth-focused, virtual pharmacy residency program in the VA.
SUMMARY: This article describes the background, premise, development, and outcomes of a virtual residency program within a large healthcare system. The benefits and challenges of implementing a telehealth-focused residency and experiences during the first 2 years of the program are reported. Relevant clinical outcomes were compared to outcomes of a traditional, on-site VA postgraduate year 2 (PGY2) ambulatory care residency program, showing experiences were comparable for residents in the primarily virtual program.
CONCLUSION: The experiences described may serve as a framework for health systems to expand access for residents through novel virtual PGY2 pharmacy residency programs focused on providing telehealth training and expertise.
SUMMARY: This article describes the background, premise, development, and outcomes of a virtual residency program within a large healthcare system. The benefits and challenges of implementing a telehealth-focused residency and experiences during the first 2 years of the program are reported. Relevant clinical outcomes were compared to outcomes of a traditional, on-site VA postgraduate year 2 (PGY2) ambulatory care residency program, showing experiences were comparable for residents in the primarily virtual program.
CONCLUSION: The experiences described may serve as a framework for health systems to expand access for residents through novel virtual PGY2 pharmacy residency programs focused on providing telehealth training and expertise.